Andreas Reinisch

Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 11

Top Venues

Medizinische Universität Graz (PHD)

This page only lists publications with an associated author ORCID identifier.

Education History

Medizinische Universität Graz

Austria

PHD :: Hematology

Publications

Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Johannes Foßelteder, Gabriel Pabst, Tommaso Sconocchia, Angelika Schlacher, Lisa Auinger, Karl Kashofer, Christine Beham-Schmid, Slave Trajanoski, Claudia Waskow, Wolfgang Schöll, Heinz Sill, Armin Zebisch, Albert Wölfler, Daniel Thomas, Andreas Reinisch
Human gene-engineered calreticulin mutant stem cells recapitulate MPN hallmarks and identify targetable vulnerabilities. Leukemia (2023)
Tommaso Sconocchia, Johannes Foßelteder, Lisa Auinger, Erdem Özkaya, Theresa Benezeder, Magdalena Lang, Christine Beham-Schmid, Gerald Hoefler, Armin Zebisch, Albert Wölfler, Heinz Sill, Peter Wolf, Herbert Strobl, Andreas Reinisch
BRAF V600E promotes DC3/monocyte differentiation in human gene-engineered HSPCs and causes multisystem histiocytosis. Leukemia (2023)
Daniel Thomas, Manhong Wu, Yusuke Nakauchi, Ming Zheng, Chloe A L Thompson-Peach, Kelly Lim, Niklas Landberg, Thomas Kohnke, Nirmal Robinson, Satinder Kaur, Monika M Kutyna, Melissa Stafford, Devendra K Hiwase, Andreas Reinisch, Gary Peltz, Ravindra Majeti
Dysregulated lipid synthesis by oncogenic IDH1 mutation is a targetable synthetic lethal vulnerability. Cancer discovery (2022)
Yusuke Nakauchi, Armon Azizi, Daniel Thomas, M Ryan Corces, Andreas Reinisch, Rajiv Sharma, David Cruz Hernandez, Thomas Köhnke, Daiki Karigane, Amy C Fan, Daniel Martinez-Krams, Melissa Stafford, Satinder Kaur, Ritika Dutta, Paul Phan, Asiri Saumya Ediriwickrema, Erin McCarthy, Yuhong Ning, Tierney Phillips, Christopher K Ellison, Gulfem D Guler, Anna Bergamaschi, Chin-Jen Ku, Samuel Levy, Ravindra Majeti
The Cell Type-Specific 5hmC Landscape and Dynamics of Healthy Human Hematopoiesis and TET2-Mutant Preleukemia. Blood cancer discovery 3 (4) (2022)
Jelena Krstic, Isabel Reinisch, Katharina Schindlmaier, Markus Galhuber, Zina Riahi, Natascha Berger, Nadja Kupper, Elisabeth Moyschewitz, Martina Auer, Helene Michenthaler, Christoph Nössing, Maria R Depaoli, Jeta Ramadani-Muja, Sinem Usluer, Sarah Stryeck, Martin Pichler, Beate Rinner, Alexander J A Deutsch, Andreas Reinisch, Tobias Madl, Riccardo Zenezini Chiozzi, Albert J R Heck, Meritxell Huch, Roland Malli, Andreas Prokesch
Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism. Science advances 8 (3) (2022)
Denis Tvorogov, Chloe A L Thompson-Peach, Johannes Foßelteder, Mara Dottore, Frank Stomski, Suraiya A Onnesha, Kelly Lim, Paul A B Moretti, Stuart M Pitson, David M Ross, Andreas Reinisch, Daniel Thomas, Angel F Lopez
Targeting human CALR-mutated MPN progenitors with a neoepitope-directed monoclonal antibody. EMBO reports 23 (4) (2022)
Trine I Jensen, Nanna S Mikkelsen, Zongliang Gao, Johannes Foßelteder, Gabriel Pabst, Esben Axelgaard, Anders Laustsen, Saskia König, Andreas Reinisch, Rasmus O Bak
Targeted regulation of transcription in primary cells using CRISPRa and CRISPRi. Genome research 31 (11) (2021)
Gabriel Pabst, Karin Lind, Ricarda Graf, Armin Zebisch, Friedrich Stölzel, Konstanze Döhner, Ellen Heitzer, Andreas Reinisch, Heinz Sill
TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model. Annals of hematology 99 (3) (2020)
Rasmus O Bak, Daniel P Dever, Andreas Reinisch, David Cruz Hernandez, Ravindra Majeti, Matthew H Porteus
Correction: Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. eLife 7 (2018)
Rasmus O Bak, Daniel P Dever, Andreas Reinisch, David Cruz Hernandez, Ravindra Majeti, Matthew H Porteus
Multiplexed genetic engineering of human hematopoietic stem and progenitor cells using CRISPR/Cas9 and AAV6. eLife 6 (2017)

Andreas Reinisch.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Andreas Reinisch